Approval · Notice of Compliance 29695 · 2022
JAMP DIGOXIN: Notice of Compliance 29695
Issued December 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29695
- Date
- December 13, 2022
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
- Canadian reference product
- TOLOXIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP DIGOXIN | Not yet assigned | — |